Can Circulating Tumor DNA Predict Who Will Benefit from Colorectal Cancer Chemotherapy?
Over 30% of patients with stage II or stage III colorectal cancer (CRC) and 60-70% of patients who undergo oligometastatic resection experience cancer recurrence. Stage II or III CRC is […]